Adar Poonawalla gets Patangrao Kadam award: The deputy chief minister of Maharashtra, Devendra Fadnavis, presents the Patangrao Kadam prize for vaccine research to Adar Poonawalla. Devendra Fadnavis also praised Serum Institute of India and its CEO Adar Poonawalla on Sunday for their work in the fight against COVID-19.
January 2023 Current Affairs Quiz
Adar Poonawalla gets Patangrao Kadam award: Key Points
- “Patangrao Kadam was a leader who created 190 institutes to provide top-notch education and produce outstanding human resources,” says the statement.
- Sharad Pawar, the leader of the Nationalist Congress Party, and Sukhvinder Singh Sukhu, the chief minister of Himachal Pradesh, both attended the ceremony.
- As SII has produced 160 vaccinations, Adar Poonawalla is continuing his father Dr. Cyrus Poonawalla’s legacy, according to Pawar.
- The chief minister of HP requested that Bharti Vidyapeeth and SII establish facilities in his state.
About Serum Institute of India (SII):
- The Serum Institute of India was founded in Pune, Maharashtra, in 1966.
- Serum Institute of India (SII) is a Pune-based biotechnology and biopharmaceuticals company in India.
- It produces more vaccines than any other country in the world. It was developed by Cyrus Poonawalla in 1966 and is a component of the Cyrus Poonawalla Group.
What all SII produce including Vaccine?
The company started out to create immunobiologicals, which were expensively imported into India. Tetanus antitoxin, snake venom, the DPT vaccine, and the MMR vaccine were some of the first goods the Serum Institute of India produced in substantial quantities.
A number of immunisations against bacterial or viral illnesses, combination vaccines, influenza vaccines, and meningococcal vaccines were added to the company’s product lines. The company also produces antisera, blood plasma, and hormone products in addition to vaccines.
As of 2014, the World Health Organization (WHO), UNICEF, and the Pan American Health Organization employed the vaccines produced by the Serum Institute of India in their global immunization campaigns (PAHO). The Poonawalla Group currently oversees the Serum Institute of India, which conducts research, development, and manufacturing.
